Co-Administration of Albumin and Furosemide in Acute Heart Failure with Diuretic Resistance


  • Jorge Fernandes Clínica de Insuficiência Cardíaca. Serviço de Medicina III. Hospital de São Francisco Xavier. Centro Hospitalar de Lisboa Ocidental. Lisboa.
  • Rita Costa Serviço de Medicina Interna. Centro Hospitalar de Vila Nova de Gaia/Espinho. Vila Nova de Gaia.
  • Renato Guerreiro Serviço de Medicina Interna. Hospital de São Francisco Xavier. Centro Hospitalar de Lisboa Ocidental. Lisboa.
  • Dulce Bonifácio Serviço de Medicina Interna. Hospital Distrital de Torres Vedras. Centro Hospitalar do Oeste. Torres Vedras.
  • Ana Rodrigues Serviço de Medicina Interna. Unidade Local de Saúde do Norte Alentejano. Hospital Santa Luzia de Elvas. Elvas.
  • Célia Henriques Clínica de Insuficiência Cardíaca. Serviço de Medicina III. Hospital de São Francisco Xavier. Centro Hospitalar de Lisboa Ocidental. Lisboa; NOVA Medical School. Faculdade de Ciências Médicas. Universidade Nova de Lisboa. Lisboa.
  • Patrícia Branco NOVA Medical School. Faculdade de Ciências Médicas. Universidade Nova de Lisboa. Lisboa; Serviço de Nefrologia. Hospital de Santa Cruz. Centro Hospitalar de Lisboa Ocidental. Lisboa.
  • Inês Araújo Clínica de Insuficiência Cardíaca. Serviço de Medicina III. Hospital de São Francisco Xavier. Centro Hospitalar de Lisboa Ocidental. Lisboa; NOVA Medical School. Faculdade de Ciências Médicas. Universidade Nova de Lisboa. Lisboa.
  • Cândida Fonseca Clínica de Insuficiência Cardíaca. Serviço de Medicina III. Hospital de São Francisco Xavier. Centro Hospitalar de Lisboa Ocidental. Lisboa; NOVA Medical School. Faculdade de Ciências Médicas. Universidade Nova de Lisboa. Lisboa.



Albumins, Diuretics, Drug Resistance, Furosemide, Heart Failure, Sodium Potassium Chloride Symporter Inhibitors


Acute heart failure is a frequent cause of hospital admission in Portugal, and has an increasing tendency given the aging population. Although most admissions for acute heart failure are caused by congestive conditions, not all patients have a congestive phenotype, reflecting the complexity of a process with multiple pathophysiological pathways. The use of diuretics, usually loop diuretics, is the mainstay of treatment for congestion. However, many patients develop resistance, thus constituting a challenge with no consensual solution to date, despite extensive debate over the years. Despite its frequent use in clinical practice, the co-administration of albumin and furosemide remains controversial in the management of patients with acute heart failure, hypoalbuminemia, and diuretic resistance. This review addresses the pathophysiological mechanisms of congestion in patients with acute heart failure and explores the theoretical basis that supports the co-administration of albumin and furosemide in this clinical context. It is intended to clarify the potential benefit of the combined approach in this specific population and identify possible gaps in the literature that could be the subject of future studies.


Download data is not yet available.


World Health Organization. Ambulatory care sensitive conditions in Portugal. Geneve: WHO; 2016.

Ellison DH, Felker GM. Diuretic treatment in heart failure. New Eng J Med. 2017;377:1964-75. DOI:

Ravnan SL, Ravnan MC, Deedwania PC. Diuretic resistance and strategies to overcome resistance in patients with congestive heart failure. Congest Heart Fail. 2002;8:80-5. DOI:

Ellison DH. Mechanistic insights into loop diuretic responsiveness in heart failure. Clin J Am Soc Nephrol. 2019;14:650-2. DOI:

Cox ZL, Lenihan DJ. Loop diuretic resistance in heart failure: resistance etiology-based strategies to restoring diuretic efficacy. J Card Fail. 2014;20:611-22. DOI:

Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P, et al. The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21:137-55. DOI:

Duffy M, Jain S, Harrell N, Kothari N, Reddi A. Albumin and furosemide combination for management of edema in nephrotic syndrome: a review of clinical studies. Cells. 2015;4:622-30. DOI:

Ter Maaten JM, Valente MA, Metra M, Bruno N, O’Connor CM, Ponikowski P, et al. A combined clinical and biomarker approach to predict diuretic response in acute heart failure. Clin Res Cardiol. 2016;105:145-53. DOI:

Monzo L, Kotrc M, Benes J, Sedlacek K, Jurcova I, Franekova J, et al. Clinical and humoral determinants of congestion in heart failure: potential role of adiponectin. Kidney Blood Press Res. 2019;44:1271-84. DOI:

Fudim M, Hernandez AF, Felker GM. Role of volume redistribution in the congestion of heart failure. J Am Heart Assoc. 2017;6. DOI:

Ellison DH. Diuretic therapy in congestive heart failure. Cardiology. 2001;96:132-43. DOI:

Jardim SI, Ramos dos Santos L, Araújo I, Marques F, Branco P, Gaspar A, et al. A 2018 overview of diuretic resistance in heart failure. Rev Port Cardiol. 2018;37:935-45. DOI:

Singh D, Shrestha K, Testani JM, Verbrugge FH, Dupont M, Mullens W, et al. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. J Card Fail. 2014;20:392-9. DOI:

Ter Maaten JM, Damman K, Hanberg JS, Givertz MM, Metra M, O’Connor CM, et al. Hypochloremia, diuretic resistance, and outcome in patients with acute heart failure. Circ Heart Fail. 2016;9:1-9. DOI:

Kumar D, Bagarhatta R. Fractional excretion of sodium and its association with prognosis of decompensated heart failure patients. J Clin Diagn Res. 2015;9:OC01-3. DOI:

Ter Maaten JM, Dunning AM, Valente MA, Damman K, Ezekowitz JA, Califf RM, et al. Diuretic response in acute heart failure-an analysis from ASCENDHF. Am Heart J. 2015;170:313-21. DOI:

Fallick C, Sobotka PA, Dunlap ME. Sympathetically mediated changes in capacitance redistribution of the venous reservoir as a cause of decompensation. Circ Heart Fail. 2011;4:669-75. DOI:

Gelman S. Venous function and central venous pressure: a physiologic story. Anesthesiology. 2008;108:735-48. DOI:

Birch DJ, Turmaine M, Boulos PB, Burnstock G. Sympathetic innervation of human mesenteric artery and vein. J Vasc Res. 2008;45:323-32. DOI:

Hainsworth R. Vascular capacitance: its control and importance. Rev Physiol Biochem Pharmacol. 1986;105:101-73. DOI:

Floras JS. Sympathetic nervous system activation in human heart failure. Clinical implications of an updated model. J Am Coll Cardiol. 2009;54:375-85. DOI:

Creager MA, Hirsch AT, Dzau VJ, Nabel EG, Cutler SS, Colucci WS. Baroreflex regulation of regional blood flow in congestive heart failure. Am J Physiol. 1990;258:H1409-14. DOI:

Rowell LB. Reflex control of regional circulations in humans. J Auton Nerv Syst. 1984;11:101-14. DOI:

Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53:589-96. DOI:

Husain-Syed F, Gröne HJ, Assmus B, Bauer P, Gall H, Seeger W, et al. Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives. ESC Heart Fail. 2021;8:183-203. DOI:

Husain-Syed F, McCullough PA, Birk HW, Renker M, Brocca A, Seeger W, et al. Cardio-pulmonary-renal interactions: a multidisciplinary approach. J Am Coll Cardiol. 2015;65:2433-48. DOI:

Mullens W, Abrahams Z, Skouri HN, Francis GS, Taylor DO, Starling RC, et al. Elevated intra-abdominal pressure in acute decompensated heart failure. A potential contributor to worsening renal function? J Am Coll Cardiol. 2008;51:300-6. DOI:

Iba T, Levy JH. Derangement of the endothelial glycocalyx in sepsis. J Thromb Haemost. 2019;17:283-94. DOI:

Aldecoa C, Llau JV, Nuvials X, Artigas A. Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review. Ann Intensive Care. 2020;10:1-12. DOI:

Rabelink TJ, de Zeeuw D. The glycocalyx - Linking albuminuria with renal and cardiovascular disease. Nat Rev Nephrol. 2015;11:667-76. DOI:

Curry FE, Michel CC. The colloid osmotic pressure across the glycocalyx: role of interstitial fluid sub-compartments in trans-vascular fluid exchange in skeletal muscle. Front Cell Dev Biol. 2021;9:1-15. DOI:

Wilcox CS. New insights into diuretic use in patients with chronic renal disease. J Am Soc Nephrol. 2002;13:798-805. DOI:

Prenner SB, Kumar A, Zhao L, Cvijic ME, Basso M, Spires T, et al. Effect of serum albumin levels in patients with heart failure with preserved ejection fraction (from the TOPCAT Trial). Am J Cardiol. 2020;125:575-82. DOI:

Yamada S, Arase H, Yoshida H, Kitamura H, Tokumoto M, Taniguchi M, et al. Malnutrition-inflammation complex syndrome and bone fractures and cardiovascular disease events in patients undergoing hemodialysis: The Q-Cohort Study. Kidney Med. 2022;4:100408. DOI:

Arques S. Albumine sérique et insuffisance cardiaque: données récentes sur un nouveau paradigme. Ann Cardiol Angeiol. 2011;60:272-8. DOI:

Grodin JL, Lala A, Stevens SR, DeVore AD, Cooper LB, AbouEzzeddine OF, et al. Clinical implications of serum albumin levels in acute heart failure: insights from DOSE-AHF and ROSE-AHF. J Card Fail. 2016;22:884-90. DOI:

Haller C. Hypoalbuminemia in renal failure: pathogenesis and therapeutic considerations. Kidney Blood Press Res. 2006;28:307-10. DOI:

Liu M, Chan CP, Yan BP, Zhang Q, Lam YY, Li RJ, et al. Albumin levels predict survival in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2012;14:39-44. DOI:

Peterson EJ, Ng TM, Patel KA, Lou M, Elkayam U. Association of admission vs. nadir serum albumin concentration with short-term treatment outcomes in patients with acute heart failure. J Int Med Res. 2018;46:3665-74. DOI:

Chalasani N, Gorski JC, Horlander JC, Craven R, Hoen H, Maya J, et al. Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. J Am Soc Nephrol. 2001;12:1010-6. DOI:

Fliser D, Zurbrüggen I, Mutschler E, Bischoff I, Nussberger J, Franek E, et al. Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int. 1999;55:629-34. DOI:

Phakdeekitcharoen B, Boonyawat K. The added-up albumin enhances the diuretic effect of furosemide in patients with hypoalbuminemic chronic kidney disease: a randomized controlled study. BMC Nephrol. 2012;13:1-9. DOI:

Bleske BE, Clark MM, Wu AH, Dorsch MP. The effect of continuous infusion loop diuretics in patients with acute decompensated heart failure with hypoalbuminemia. J Cardiovasc Pharmacol Ther. 2013;18:334-7. DOI:

Heart Failure Society of America. Executive summary: HFSA 2010 comprehensive heart failure practice guideline. J Card Fail. 2010;16:475-539. DOI:

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the american college of cardiology foundation/american heart association task force on practice guidelines. Circulation. 2013;128:240-327. DOI:

Makhoul N, Riad T, Friedstrom S, Zveibil FR. Frusemide in pulmonary oedema: continuous versus intermittent. Clin Intensive Care. 1997;8:273-6. DOI:

Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med. 2005;33:1681-7. DOI:

Oczkowski SJ, Mazzetti I. Colloids to improve diuresis in critically ill patients: a systematic review. J Intensive Care. 2014;2:1-6. DOI:

Oczkowski SJ, Klotz L, Mazzetti I, Alshamsi F, Chen ML, Foster G, et al. Furosemide and albumin for diuresis of edema (FADE): a parallel-group, blinded, pilot randomized controlled trial. J Crit Care. 2018;48:462-7. DOI:

Arques S, Ambrosi P. Human serum albumin in the clinical syndrome of heart failure. J Card Fail. 2011;17:451-8. DOI:

Clarke MM, Dorsch MP, Kim S, Aaronson KD, Koelling TM, Bleske BE. Baseline albumin is associated with worsening renal function in patients with acute decompensated heart failure receiving continuous infusion loop diuretics. Pharmacotherapy. 2013;33:583-8. DOI:

Kirchner KA, Voelker JR, Brater DC. Binding inhibitors restore furosemide potency in tubule fluid containing albumin. Kidney Int. 1991;40:418-24. DOI:

Inoue M, Okajima K, Itoh K, Ando Y, Watanabe N, Yasaka T, et al. Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int. 1987;32:198-203. DOI:

Charokopos A, Griffin M, Rao VS, Inker L, Sury K, Asher J, et al. Serum and urine albumin and response to loop diuretics in heart failure. Clin J Am Soc Nephrol. 2019;14:712-8. DOI:

Doungngern T, Huckleberry Y, Bloom JW, Erstad B. Effect of albumin on diuretic response to furosemide in patients with hypoalbuminemia. Am J Crit Care. 2012;21:280-6. DOI:

Kitsios GD, Mascari P, Ettunsi R, Gray AW. Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis. J Crit Care. 2014;29:253-9. DOI:

Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797-805. DOI:

Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013;310:2533-43. DOI:




How to Cite

Fernandes J, Costa R, Guerreiro R, Bonifácio D, Rodrigues A, Henriques C, Branco P, Araújo I, Fonseca C. Co-Administration of Albumin and Furosemide in Acute Heart Failure with Diuretic Resistance. Acta Med Port [Internet]. 2023 Feb. 10 [cited 2024 May 28];36(3):193-201. Available from:



Review Articles